Edmund C Lattime

Title: The Innovative Contributions of Edmund C. Lattime

Introduction

Edmund C. Lattime is a prominent inventor based in Princeton, NJ (US), known for his significant contributions to the field of immunology and cancer treatment. With a total of 3 patents, Lattime has developed groundbreaking methods that utilize vaccinia virus vectors to enhance immune responses and treat various forms of cancer.

Latest Patents

Lattime's latest patents include a method of inducing an immune response using vaccinia virus recombinants. This innovative approach involves generating a vaccinia virus vector capable of inducing expression of selected immune-active cytokines within tumors. By injecting this vector into a tumor, the tumor cells can express the selected cytokine, thereby enhancing the immune response. Additionally, he has developed methods for treating bladder cancer through the administration of wild-type vaccinia virus, showcasing his commitment to advancing cancer therapies.

Career Highlights

Edmund C. Lattime is affiliated with Thomas Jefferson University, where he continues to conduct research and develop new therapeutic strategies. His work has been instrumental in exploring the potential of vaccinia virus vectors in cancer treatment, contributing to the broader understanding of immunotherapy.

Collaborations

Lattime has collaborated with notable colleagues, including Michael J. Mastrangelo and David Berd, further enriching his research endeavors and expanding the impact of his work in the scientific community.

Conclusion

Edmund C. Lattime's innovative work in the field of immunology and cancer treatment exemplifies the potential of using viral vectors to enhance immune responses. His contributions continue to pave the way for new therapeutic approaches in oncology.